| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on February 6, 2004
From Department of Physiology (S.Y.T., X.Y., C.M.W., Y.H.), Chinese University of Hong Kong, China; Department of Anatomy (F.L.C.), Chinese University of Hong Kong, China; Franz Volhard Clinic (K.E., M.G.), Berlin, Germany; and Department of Physiology (K.E., M.G.), LSU Health Sciences Center, New Orleans, La. * To whom correspondence should be addressed. E-mail: yu-huang{at}cuhk.edu.hk.
Background and Purpose--Because of their mixed estrogen-agonist and estrogen-antagonist properties, selective estrogen receptor modulators (SERMs) are considered promising substitutes for hormone replacement therapy. Raloxifene and other SERMs confer estrogen-like cardiovascular protective effects but lack the carcinogenic activity of exogenous estrogen. However, little is known about the cerebrovascular action of raloxifene. Therefore, we studied the effects of raloxifene on the mechanisms regulating rat cerebral artery tone. Methods and Results--Ring segments of the isolated rat posterior communicating cerebral arteries were mounted in a microvessel myograph for measurement of isometric tension. Whole-cell L-type voltage-sensitive Ca2+ currents were recorded using the perforated patch-clamp technique. Raloxifene (0.1 to 10 µmol/L) reduced the contractile responses to U46619, phenylephrine, and endothelin-1 in normal Krebs solution or to CaCl2 in Ca2+-free, high K+-containing solution. Raloxifene-induced relaxation was identical in endothelium-intact and endothelium-denuded rings. ICI 182780 had no effect on raloxifene-induced relaxation. Raloxifene reduced L-type Ca2+ currents with a pD2 of 5.98±0.06, close to that (6.44±0.09) for raloxifene-induced relaxation of 60 mmol/L K+-contracted rings. Conclusions--This study demonstrates that raloxifene acutely relaxes rat cerebral arteries largely via an endothelium-independent mechanism, involving inhibition of Ca2+ influx through L-type Ca2+ channels.
Revised on March 17, 2004
Accepted on March 31, 2004
Raloxifene Relaxes Rat Cerebral Arteries In Vitro and Inhibits L-Type Voltage-Sensitive Ca2+ Channels
Suk-Ying Tsang PhD;
This article has been cited by other articles:
![]() |
E. Murakami, H. Iwata, M. Imaizumi, and H. Takemura Prevention of arterial graft spasm by botulinum toxin: an in-vitro experiment Interactive CardioVascular and Thoracic Surgery, September 1, 2009; 9(3): 395 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bolanz, M. A. Hediger, and C. P. Landowski The role of TRPV6 in breast carcinogenesis Mol. Cancer Ther., February 1, 2008; 7(2): 271 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pinna, C. Bolego, P. Sanvito, V. Pelosi, R. Baetta, A. Corsini, R. M. Gaion, and A. Cignarella Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Leung, X. Yao, C.-W. Lau, W.-H. Ko, L. Lu, and Y. Huang Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influx Am J Physiol Renal Physiol, July 1, 2005; 289(1): F137 - F144. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Chan, F.-P. Leung, X. Yao, C.-W. Lau, P. M. Vanhoutte, and Y. Huang Raloxifene Relaxes Rat Pulmonary Arteries and Veins: Roles of Gender, Endothelium, and Antagonism of Ca2+ Influx J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1266 - 1271. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |